These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis. Valentin-Torres A; Savarin C; Hinton DR; Phares TW; Bergmann CC; Stohlman SA J Neuroinflammation; 2016 Feb; 13():46. PubMed ID: 26906225 [TBL] [Abstract][Full Text] [Related]
3. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788 [TBL] [Abstract][Full Text] [Related]
4. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Murphy AC; Lalor SJ; Lynch MA; Mills KH Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983 [TBL] [Abstract][Full Text] [Related]
5. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. Valentin-Torres A; Savarin C; Barnett J; Bergmann CC J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells. Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119 [TBL] [Abstract][Full Text] [Related]
7. Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. Defaux A; Zurich MG; Braissant O; Honegger P; Monnet-Tschudi F J Neuroinflammation; 2009 May; 6():15. PubMed ID: 19422681 [TBL] [Abstract][Full Text] [Related]
8. The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis. Lavrnja I; Savic D; Bjelobaba I; Dacic S; Bozic I; Parabucki A; Nedeljkovic N; Pekovic S; Rakic L; Stojiljkovic M J Pharmacol Sci; 2012; 119(3):221-32. PubMed ID: 22785017 [TBL] [Abstract][Full Text] [Related]
9. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642 [TBL] [Abstract][Full Text] [Related]
10. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550 [TBL] [Abstract][Full Text] [Related]
11. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response. Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423 [TBL] [Abstract][Full Text] [Related]
12. Reduced cuprizone-induced cerebellar demyelination in mice with astrocyte-targeted production of IL-6 is associated with chronically activated, but less responsive microglia. Petković F; Campbell IL; Gonzalez B; Castellano B J Neuroimmunol; 2017 Sep; 310():97-102. PubMed ID: 28778453 [TBL] [Abstract][Full Text] [Related]
13. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651 [TBL] [Abstract][Full Text] [Related]
14. Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice. Valero-Esquitino V; Lucht K; Namsolleck P; Monnet-Tschudi F; Stubbe T; Lucht F; Liu M; Ebner F; Brandt C; Danyel LA; Villela DC; Paulis L; Thoene-Reineke C; Dahlöf B; Hallberg A; Unger T; Sumners C; Steckelings UM Clin Sci (Lond); 2015 Jan; 128(2):95-109. PubMed ID: 25052203 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation. Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED Front Immunol; 2018; 9():50. PubMed ID: 29422898 [TBL] [Abstract][Full Text] [Related]
16. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. Ding X; Yan Y; Li X; Li K; Ciric B; Yang J; Zhang Y; Wu S; Xu H; Chen W; Lovett-Racke AE; Zhang GX; Rostami A J Immunol; 2015 May; 194(9):4251-64. PubMed ID: 25795755 [TBL] [Abstract][Full Text] [Related]
17. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis. Pagenstecher A; Lassmann S; Carson MJ; Kincaid CL; Stalder AK; Campbell IL J Immunol; 2000 May; 164(9):4481-92. PubMed ID: 10779748 [TBL] [Abstract][Full Text] [Related]
18. IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability. Hindinger C; Bergmann CC; Hinton DR; Phares TW; Parra GI; Hussain S; Savarin C; Atkinson RD; Stohlman SA PLoS One; 2012; 7(7):e42088. PubMed ID: 22848713 [TBL] [Abstract][Full Text] [Related]
19. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis. Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346 [TBL] [Abstract][Full Text] [Related]
20. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis. Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]